Mar­ket­ingRx roundup: Pfiz­er talks about its ‘Char­lie’ AI mar­ket­ing bot; Gilead pledges $12M for HIV pre­ven­tion

Pfiz­er opens up about its gen­er­a­tive AI mar­ket­ing plat­form: The drug­mak­er is rolling out a new ar­ti­fi­cial in­tel­li­gence plat­form for mar­ket­ing — named “Char­lie” af­ter its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER